[2-[(2-chloro-6-methylaminopurin-9-yl)methyl]-3-phosphonooxypropyl] dihydrogen phosphate
[2-[(2-chloro-6-methylaminopurin-9-yl)methyl]-3-phosphonooxypropyl] dihydrogen phosphate Basic information
- Product Name:
- [2-[(2-chloro-6-methylaminopurin-9-yl)methyl]-3-phosphonooxypropyl] dihydrogen phosphate
- Synonyms:
-
- MRS2298, CID:10432920
- [2-[(2-chloro-6-methylaminopurin-9-yl)methyl]-3-phosphonooxypropyl] dihydrogen phosphate
- 1,3-Propanediol, 2-[[2-chloro-6-(methylamino)-9H-purin-9-yl]methyl]-, 1,3-bis(dihydrogen phosphate)
- CAS:
- 491611-43-9
- MF:
- C10H16ClN5O8P2
- MW:
- 431.66
- Mol File:
- 491611-43-9.mol
More
Less
[2-[(2-chloro-6-methylaminopurin-9-yl)methyl]-3-phosphonooxypropyl] dihydrogen phosphate Chemical Properties
- Boiling point:
- 735.8±70.0 °C(Predicted)
- Density
- 2.03±0.1 g/cm3(Predicted)
- pka
- 1.55±0.10(Predicted)
More
Less
[2-[(2-chloro-6-methylaminopurin-9-yl)methyl]-3-phosphonooxypropyl] dihydrogen phosphate Usage And Synthesis
Description
MRS2298 is a potent antagonists of the P2Y 1 receptor, which has antiaggregatory activity in human platelets.
Uses
MRS2298? is a potent acyclic P2Y1 receptor antagonist with a Ki of 29.6 nM. MRS2298 inhibits the ADP-induced aggregation of human platelets with an IC50 of 62.8 nM. MRS2298 inhibits Ca2+ rise in platelets with an IC50 of 810 nM[1].
References
[1] Marco Cattaneo, et al. Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor. Biochem Pharmacol. 2004 Nov 15;68(10):1995-2002. DOI:10.1016/j.bcp.2004.06.026
[2-[(2-chloro-6-methylaminopurin-9-yl)methyl]-3-phosphonooxypropyl] dihydrogen phosphateSupplier
Jinan Yaoyan Pharmaceutical Co., Ltd.
- Tel
- jnyaoyan@163.com
Nanjing Meihao Pharmaceutical Technology Co., Ltd.
- Tel
- meitaochem@126.com
- meitaochem@126.com
TargetMol Chemicals Inc.
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
JinOu Biomedical (Nanjing) Co., Ltd.
- Tel
- 13000000000
- jinoupharma@163.com
TargetMol Chemicals Inc.
- Tel
- 15002134094
- marketing@targetmol.cn